Int J STD AIDS. 2010 Feb; 21(2): 77-81
McCarty EJ, Dinsmore WW

Premature ejaculation (PE) is the most common male sexual problem worldwide affecting 22-38% of men. It has a significant morbidity both on patients and their partners, causing distress, anxiety and relationship difficulties. The mainstay of treatment is a combined approach using behavioural therapies and non-licensed medication such as topical anaesthetic preparations, selective serotonin re-uptake inhibitors and phosphodiesterase-5 inhibitors. In recent years, there has been a greater emphasis placed on researching novel treatments and exploring the on-demand use of current preparations. This review provides an overview of current accepted treatments and emerging agents for the use in PE.

Read Full Article

Share This:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google
  • MisterWong
  • Propeller
  • Slashdot
  • Spurl
  • StumbleUpon
  • Technorati

Filed under: Premature Ejaculation Research

Like this post? Subscribe to my RSS feed and get loads more!